Dna X (SONM) Cash from Investing Activities (2018 - 2026)

Dna X has reported Cash from Investing Activities for 8 years, with the latest figure at $3.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities changed N/A year-over-year to $3.4 million; the trailing twelve-month figure through Mar 2026 stood at $3.2 million (changed N/A YoY), and the FY2024 full-year result was -$214000.0, down 494.44% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $3.4 million, up from -$8000.0 in the prior quarter.
• The five-year high for Cash from Investing Activities was $3.4 million in Q1 2026, with the low at -$137000.0 in Q3 2024.
• Historically, Cash from Investing Activities has averaged $312300.0 across 4 years, with a median of -$5500.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 92.31% — and 2024, when it plunged 13600.0%.
• Dna X's Cash from Investing Activities stood at -$2000.0 in 2022, then tumbled by 500.0% to -$12000.0 in 2023, then jumped by 33.33% to -$8000.0 in 2024, then soared by 42075.0% to $3.4 million in 2026.
• The last three Cash from Investing Activities figures came in at $3.4 million (Q1 2026), -$8000.0 (Q4 2024), and -$137000.0 (Q3 2024), per Business Quant data.